Comparative clinical efficacy and safety of biosimilar <scp>ABP</scp> 959 and eculizumab reference product in patients with paroxysmal nocturnal hemoglobinuria

Authors:

Published: 0000-00-00

DOI: HTTPS://DOI.ORG/https://doi.org/10.1002/ajh.27456

Keywords:

Abstract:

Source: